Correlation Between INtRON Biotechnology and Daihan Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both INtRON Biotechnology and Daihan Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INtRON Biotechnology and Daihan Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iNtRON Biotechnology and Daihan Pharmaceutical CoLtd, you can compare the effects of market volatilities on INtRON Biotechnology and Daihan Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INtRON Biotechnology with a short position of Daihan Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of INtRON Biotechnology and Daihan Pharmaceutical.

Diversification Opportunities for INtRON Biotechnology and Daihan Pharmaceutical

-0.31

Correlation Coefficient

INtRON Biotechnology  Daihan Pharmaceutical

Very good diversification

The 3 months correlation between INtRON and Daihan is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding iNtRON Biotechnology and Daihan Pharmaceutical CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daihan Pharmaceutical and INtRON Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iNtRON Biotechnology are associated (or correlated) with Daihan Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daihan Pharmaceutical has no effect on the direction of INtRON Biotechnology i.e., INtRON Biotechnology and Daihan Pharmaceutical go up and down completely randomly.

Pair Corralation between INtRON Biotechnology and Daihan Pharmaceutical

Assuming the 90 days trading horizon iNtRON Biotechnology is expected to generate 3.42 times more return on investment than Daihan Pharmaceutical. However, INtRON Biotechnology is 3.42 times more volatile than Daihan Pharmaceutical CoLtd. It trades about 0.23 of its potential returns per unit of risk. Daihan Pharmaceutical CoLtd is currently generating about 0.07 per unit of risk. If you would invest  506,286  in iNtRON Biotechnology on October 12, 2024 and sell it today you would earn a total of  72,714  from holding iNtRON Biotechnology or generate 14.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

iNtRON Biotechnology  vs.  Daihan Pharmaceutical CoLtd

iNtRON Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, INtRON Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Daihan Pharmaceutical

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Daihan Pharmaceutical CoLtd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with INtRON Biotechnology and Daihan Pharmaceutical

The main advantage of trading using opposite INtRON Biotechnology and Daihan Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INtRON Biotechnology position performs unexpectedly, Daihan Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will offset losses from the drop in Daihan Pharmaceutical's long position.

The idea behind iNtRON Biotechnology and Daihan Pharmaceutical CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.